everolimus ratiopharm 2.5 mg tabletti
ratiopharm gmbh - everolimuusi - tabletti - 2.5 mg - everolimuusi
everolimus ratiopharm 5 mg tabletti
ratiopharm gmbh - everolimuusi - tabletti - 5 mg - everolimuusi
everolimus ratiopharm 10 mg tabletti
ratiopharm gmbh - everolimuusi - tabletti - 10 mg - everolimuusi
cosacthen vet 0.25 mg/ml injektioneste, liuos
dechra regulatory b.v. - tetracosactide acetate - injektioneste, liuos - 0.25 mg/ml - tetrakosaktidi
furosemide norameda 10 mg/ml injektio-/infuusioneste, liuos
uab norameda - furosemide - injektio-/infuusioneste, liuos - 10 mg/ml - furosemidi
coxevac
ceva santé animale - inaktivoitu coxiella burnetii -rokote, nine mile -kanta - immunologicals for bovidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - goats; cattle - cattle: , for the active immunisation of cattle to lower the risk for non-infected animals vaccinated when non-pregnant to become shedder (5 times lower probability in comparison with animals receiving a placebo), and to reduce shedding of coxiella burnetii in these animals via milk and vaginal mucus. , onset of immunity: not established. , duration of immunity: 280 days after completion of the primary vaccination course. , goats: , for the active immunisation of goats to reduce abortion caused by coxiella burnetii and to reduce shedding of the organism via milk, vaginal mucus, faeces and placenta. , onset of immunity: not established. , duration of immunity: one year after completion of the primary vaccination course.
tranexamic acid baxter 100 mg/ml injektio-/infuusioneste, liuos
baxter holding b.v. - tranexamic acid - injektio-/infuusioneste, liuos - 100 mg/ml - traneksaamihappo
metoclopramide baxter 5 mg/ml injektioneste, liuos
baxter holding b.v. - metoclopramide hydrochloride - injektioneste, liuos - 5 mg/ml - metoklopramidi